Journal
American Journal of Kidney Diseases
Publication Date
9-1-2023
Volume
82
Issue
3
First Page
322
Last Page
332.e1
Document Type
Open Access Publication
DOI
10.1053/j.ajkd.2023.03.010
Rights and Permissions
Menez S, Coca SG, Moledina DG, Wen Y, Chan L, Thiessen-Philbrook H, Obeid W, Garibaldi BT, Azeloglu EU, Ugwuowo U, Sperati CJ, Arend LJ, Rosenberg AZ, Kaushal M, Jain S, Wilson FP, Parikh CR; TRIKIC Consortium. Evaluation of Plasma Biomarkers to Predict Major Adverse Kidney Events in Hospitalized Patients With COVID-19. Am J Kidney Dis. 2023 Sep;82(3):322-332.e1. doi: 10.1053/j.ajkd.2023.03.010. © 2023 by the National Kidney Foundation, Inc. Published by Elsevier Inc. This is an open access article under the CC BYNC-ND license (http:// creativecommons.org/ licenses/by-nc-nd/4.0/).
Recommended Citation
Menez, Steven; Kaushal, Madhurima; Jain, Sanjay; and et al., "Evaluation of plasma biomarkers to predict major adverse kidney events in hospitalized patients with COVID-19." American Journal of Kidney Diseases. 82, 3. 322 - 332.e1. (2023).
https://digitalcommons.wustl.edu/oa_4/2827
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
